RARE NEWS why is Ultragenyx Pharmaceutical Inc. price falling or rising
RARE NEWS reasons for why stock price of Ultragenyx Pharmaceutical Inc. is falling or rising
RARE Ultragenyx Pharmaceutical is falling or rising technical reasons
Technical analysis forecast for Ultragenyx Pharmaceutical Stock is that its in a downtrend for shortterm, and I will avoid taking a BUY or a LONG trade in this stock. Look for opportunities to sell or SHORT Ultragenyx Pharmaceutical RARE at this time. Stock is falling and might fall more.
It appears as if Ultragenyx Pharmaceutical RARE gave a large move recently.
Stock of Ultragenyx Pharmaceutical (RARE) is trading below an important moving average line, but it crossed this line recently, which means that it could show a small or a large recovery soon enough depending on its trend.
My analysis of Ultragenyx Pharmaceutical is bearish for shortterm, but trade for tomorrow is selective. Take a sell trade only if Ultragenyx Pharmaceutical stays below 23.9, but if it comes above 23.9, then a intra day buy could be more profitable.
If you take a sell trade below 23.9, then use 23.9 as stoploss and 23.1 as target. However if you take a buy trade in Ultragenyx Pharmaceutical, then use 23.9 as stoploss and 24.62 as target.
RARE Ultragenyx Pharmaceutical is falling or rising NEWS fundamental reasons
Indian stocks enjoy a rare combination, makes a case for re-rating: Morgan Stanley's Ridham Desai Morgan Stanley sees Indian equities entering a rare phase that supports a valuation re-rating, driven by policy stimulus, improving earnings, weak foreign positioning and attractive relative valuations. With macro stability improving and growth acceleratin - NEWS as on 2026-02-06 indiatimes.com
Defence, semi-conductors, rare earths : Where to invest after Budget 2026 Real sinals are embedded in the Budget document-policy continuity, withdrawal of customs duties on manufactured goods, and a clear shift towards strategic sectors like defence, semiconductors - NEWS as on 2026-02-05 business-standard.com
Budget relief on the label: Govt proposes to drop duty on rare disease drugs The Indian budget proposes exempting seven rare disease drugs from import duties. This move aims to lower costs for expensive life-saving medicines. Patient groups welcome the relief for out-of-pocket expenses. However, some believe duty cuts alone will no - NEWS as on 2026-02-03 indiatimes.com
More announcements and NEWS
RARE Ultragenyx Pharmaceutical Inc. current price & indicator signals
Recent prices of RARE Ultragenyx Pharmaceutical Inc. are as follows: Daily volume is divided by 10 day averaged volume
| Date | Close | Range | Change % | Volume |
| 09 Mon Feb 2026 | 23.88 | 23.78 to 24.67 | -3.32% | 0.76 times |
| 06 Fri Feb 2026 | 24.70 | 23.89 to 24.87 | 3.83% | 1.2 times |
| 05 Thu Feb 2026 | 23.79 | 23.76 to 24.93 | -3.65% | 0.77 times |
| 04 Wed Feb 2026 | 24.69 | 24.08 to 25.07 | -0.44% | 0.83 times |
| 03 Tue Feb 2026 | 24.80 | 24.36 to 25.82 | 0.16% | 1.16 times |
| 02 Mon Feb 2026 | 24.76 | 23.56 to 24.91 | 2.87% | 1.54 times |
| 30 Fri Jan 2026 | 24.07 | 23.26 to 24.59 | -0.82% | 1.69 times |
| 29 Thu Jan 2026 | 24.27 | 23.98 to 24.70 | -0.7% | 0.75 times |
| 28 Wed Jan 2026 | 24.44 | 24.33 to 24.96 | -0.73% | 0.81 times |
| 27 Tue Jan 2026 | 24.62 | 24.23 to 25.00 | 1.32% | 0.73 times |
| 26 Mon Jan 2026 | 24.30 | 23.96 to 24.90 | 0.37% | 0.53 times |
| 23 Fri Jan 2026 | 24.21 | 23.16 to 24.53 | 3.46% | 1.23 times |
Videos related to: RARE NEWS why is Ultragenyx Pharmaceutical Inc. price falling or rising
Hindi Basics How To Trade In FnO Futures Options Stock Market
- NASDAQ Screeners
- NASDAQ Daily Screener
- NASDAQ Weekly Screener
- NASDAQ Monthly Screener
- Support & Resistance
- NASDAQ Shares Near Support
- NASDAQ Shares Near Resistance


